Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion type Assertion NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_head.
- NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion description "[Recent markers such as the NPM1 mutations in AML or the JAK2V617F mutation in the CMPD can be exactly quantified by real-time PCR and were evaluated for their prognostic value in the post transplantation phase and for their utility to plan adoptive immunotherapy in case of molecular relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_provenance.
- NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion evidence source_evidence_literature NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_provenance.
- NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion SIO_000772 18587431 NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_provenance.
- NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion wasDerivedFrom befree-2016 NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_provenance.
- NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_assertion wasGeneratedBy ECO_0000203 NP679258.RAOSrBqQsrmiCHD1h4KT-9stkW3xab0CAPF-xfPs5rbBM130_provenance.